Nellie A Campbell

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Venues

Cancers

This page only lists publications with an associated author ORCID identifier.

Publications

Faizal Z Asumda, Nellie A Campbell, Mohamed A Hassan, Reza Fathi, Daniella F Vasquez Rico, Melanie Kiem, Ethan V Vang, Yo Han Kim, Xin Luo, Daniel R O'Brien, Sarah A Buhrow, Joel M Reid, Michael J Moore, Vered Katz Ben-Yair, Mark L Levitt, Jennifer L Leiting, Amro M Abdelrahman, Xinli Zhu, Fabrice Lucien, Mark J Truty, Lewis Rowland Roberts
Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts. Cancers 16 (5) (2024)
Faizal Z Asumda, Nellie A Campbell, Mohamed A Hassan, Reza Fathi, Daniella F Vasquez Rico, Melanie Kiem, Ethan V Vang, Yo Han Kim, Xin Luo, Daniel R O'Brien, Sarah A Buhrow, Joel M Reid, Michael J Moore, Vered Katz Ben-Yair, Mark L Levitt, Jennifer L Leiting, Amro M Abdelrahman, Xinli Zhu, Fabrice Lucien, Mark J Truty, Lewis Rowland Roberts
Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts. Cancers 16 (5) (2024)
Faizal Z Asumda, Nellie A Campbell, Mohamed A Hassan, Reza Fathi, Daniella F Vasquez Rico, Melanie Kiem, Ethan V Vang, Yo Han Kim, Xin Luo, Daniel R O'Brien, Sarah A Buhrow, Joel M Reid, Michael J Moore, Vered Katz Ben-Yair, Mark L Levitt, Jennifer L Leiting, Amro M Abdelrahman, Xinli Zhu, Fabrice Lucien, Mark J Truty, Lewis Rowland Roberts
Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts. Cancers 16 (5) (2024)
Amro M Abdelrahman, Jun Yin, Roberto Alva-Ruiz, Jennifer A Yonkus, Jennifer L Leiting, Isaac T Lynch, Alessandro Fogliati, Nellie A Campbell, Danielle M Carlson, Lewis Rowland Roberts, Gregory J Gores, Rory L Smoot, Rondell P Graham, Thorvardur R Halfdanarson, Mark J Truty
Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States. Cancers 15 (3) (2023)
Amro M Abdelrahman, Jun Yin, Roberto Alva-Ruiz, Jennifer A Yonkus, Jennifer L Leiting, Isaac T Lynch, Alessandro Fogliati, Nellie A Campbell, Danielle M Carlson, Lewis Rowland Roberts, Gregory J Gores, Rory L Smoot, Rondell P Graham, Thorvardur R Halfdanarson, Mark J Truty
Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States. Cancers 15 (3) (2023)
Xiwei Ding, Kais Zakharia, Catherine D Moser, Nellie A Campbell, Chunling Hu, Nataliya Razumilava, Roongruedee Chaiteerakij, Hassan M Shaleh, Patricia T Greipp, Rondell P Graham, Xiaoping Zou, Vishal S Chandan, Lewis Rowland Roberts
Establishment and Characterization of a New Human Intrahepatic Cholangiocarcinoma Cell Line LIV27. Cancers 14 (20) (2022)

Nellie A Campbell.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nellie A Campbell